RHRos Hastings

Ros Hastings

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Ros Hastings has a total of 7 co-authors. Here are the top co-authors by number of shared publications:

  • Eca Pwg Co-Ordinators

    UKNEQAS for Clinical Cytogenetics, Women's Centre, John Radcliffe Hospital, Oxford, OX3 9DU, UK

    1 shared publication
  • Franca Dagna Bricarelli

    UKNEQAS for Clinical Cytogenetics, Women's Centre, John Radcliffe Hospital, Oxford, OX3 9DU, UK

    1 shared publication
  • Philippos C Patsalis

    UKNEQAS for Clinical Cytogenetics, Women's Centre, John Radcliffe Hospital, Oxford, OX3 9DU, UK

    1 shared publication
  • Rod Howell

    Oxford Radcliffe Hospital

    1 shared publication
  • Rod T. Howell

    CEQA, Cytogenetics European Quality Assessment, Oxford Radcliffe Hospitals NHS Trust, Oxford, UK

    1 shared publication
  • Simona Cavani

    UKNEQAS for Clinical Cytogenetics, Women's Centre, John Radcliffe Hospital, Oxford, OX3 9DU, UK

    1 shared publication

Latest Publications

  • Quality Control in FISH as Part of a Laboratory’s Quality Management System

    by Ros Hastings

    Quality control in the laboratory setting requires the establishment of a quality management system (QMS) that covers training, standard operating procedures, internal quality control, validation of tests, and external quality assessment (EQA). Laboratory accreditation through inspection by an external body is also desirable as this provides an effective procedure for assuring quality and also reassures the patient that the laboratory is working to acceptable international standards. The implementation of fluorescence in situ hybridisation (FISH) in the routine diagnostic laboratory requires rigorous quality control with attention to when it is appropriate to apply the technology, a systematic approach to the validation of probes, policies and procedures documenting the analytical validity of all FISH tests performed, technical procedures involved, and a comprehensive means of reporting results. Knowledge of the limitations of any FISH test is required in relation to the probe and/or tissue being examined, since errors of analysis and interpretation can result in incorrect patient management. A structured QMS with internal quality control and regular audits will minimise the error rate.


  • Quality in Cytogenetics

    by Ros Hastings, Rod Howell

  • The importance and value of EQA for diagnostic genetic laboratories

    by Ros J. Hastings, Rod T. Howell

    Quality control in a laboratory setting requires the establishment of effective training, standard operating procedures, internal quality control, validation of tests and external quality assessment (EQA). A structured quality management system subject to regular internal and external audits will minimise the error rate. EQA, therefore, gives assurance, both to patients and referring clinicians, that the diagnostic laboratory is competent to produce results that are reliable and accurate. EQA is educational and aims to improve and validate the overall quality of genetic service to the user. Regular EQA assessment compares laboratory performance against set standards and also allows comparison between laboratories. Sometimes EQA can also help to define good standards (best practice), although this does depend on the type of EQA test. EQA interprets best practice standards (=quality) into a numerical score (=quantity). While international bodies or professional organisations set these standards, EQA is able to assess whether these standards are met, with any omissions resulting in a reduction in the total score. Although EQA has an educational role rather than a punitive role, critical errors affecting clinical management will result in a laboratory receiving a poor performance categorisation. Accurate analysis and interpretation are essential quality parameters that require extensive knowledge of the aetiology of genetic abnormalities/disease and risk factors. Training of staff in interpretation of the results together with a comprehensive means of reporting normal and abnormal genetic results underpins the diagnostic service to the patient. Poor-performing laboratories are, therefore, encouraged to review their internal processes. EQA schemes that have been established for many years have seen improvements in the analytical and reporting content over time, thereby improving the quality of diagnostic service available to patients.


  • Cytogenetic Guidelines and Quality Assurance: a common European framework for quality assessment for constitutional and acquired cytogenetic investigations

    by Eca Pwg Co-Ordinators, Ros J Hastings, Simona Cavani, Franca Dagna Bricarelli, Philippos C Patsalis, Ulf Kristoffersson